NanoViricides Reports Positive Anti-viral Effect of HIV Drug
NanoViricides (OTCBB:NNVC) announced Monday that its anti-HIV drug candidate, HIVCide, achieved a…
InVivo Therapeutics Treats the Spinal Cord Itself, A Novel Technology
Frank Reynolds, President and CEO of InVivo Therapeutics was interviewed by OneMedRadio…
January 9-12, 2012 OneMedForum San Francisco
The 5th Annual OneMedForum San Francisco 2012 is around the corner and…
IntelliCell BioSciences To Open Adipose Tissue Processing Centre in Houston
IntelliCell BioSciences, Inc. (OTCQB: SVFC), maker of stromal vascular fraction that contains…
Bio-Rad receives pre-market approval for HIV test from FDA
Bio-Rad Laboratories (NYSE:BIO) announced Monday it received FDA premarket approval for its…
Arun Menawat Discusses Novadaq Technologies, a Surgical Imaging Company
Novadaq Technologies (TSX:NDQ) President & CEO Arun Menawat was interviewed by OneMedRadio. …
Leading Expert On U.S. Health Reform Gives His Two Cents
Paul Keckley noted that things may get worse before they get better…
Cervical Cancer Vaccine Yields Long Term Positive Effects
Inovio Pharmaceuticals (AMEX:INO) reported Friday the positive long-term effects of its VGX-3100…
CEO Interview: Michael Moe On GSV Capital, A New Vehicle To Finance Growth Companies
GSV Capital Founder & CEO Michael Moe interviewed by OneMedRadio. GSV raised…